Risk assessment of H2N2 influenza viruses from the avian reservoir

Journal of Virology

Volumn 88, Issue 2, 2014, Pages 1175-1188

  Jones, Jeremy C ^a   Baranovich, Tatiana ^a   Marathe, Bindumadhav M ^a   Danner, Angela F ^a   Seiler, Jon P ^a   Franks, John ^a   Govorkova, Elena A ^a   Krauss, Scott ^a   Webster, Robert G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE DERIVATIVE; INFLUENZA VACCINE; OSELTAMIVIR; PB2 PROTEIN; PERAMIVIR; RECEPTOR; SIALIC ACID RECEPTOR; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ; VIRUS PROTEIN; ZANAMIVIR;

ANIMAL CELL; ANIMAL TISSUE; ANTIGENICITY; ANTIVIRAL RESISTANCE; ARTICLE; AVIAN INFLUENZA; BIRD; CONTROLLED STUDY; FERRET; HUMAN; HUMAN CELL; IC 50; INFLUENZA A (H2N2); INFLUENZA VIRUS A H2N2; MOLECULAR EVOLUTION; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RECEPTOR BINDING; RISK ASSESSMENT; SWINE; VIRUS CARRIER; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; ANIMALS, WILD; BIRDS; CELL LINE; DISEASE RESERVOIRS; FERRETS; HUMANS; INFLUENZA A VIRUS, H2N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MICE; MICE, INBRED DBA; RISK ASSESSMENT; SWINE; VIRUS REPLICATION;

EID: 84891714819     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02526-13     Document Type: Article

References (57)

1. Scholtissek C, Rohde W, Von Hoyningen V, Rott R. 1978. On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 87:13-20. http://dx.doi.org/10.1016/0042-6822(78)90153-8.
2. Webster RG. 1997. Predictions for future human influenza pandemics. J. Infect. Dis. 176(Suppl 1):S14-S19.
3. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. 1998. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J. Infect. Dis. 178:53-60. http://dx.doi.org/10.1086/515616.
4. Kawaoka Y, Krauss S, Webster RG. 1989. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J. Virol. 63:4603-4608.
5. Palese P, Wang TT. 2011. Why do influenza virus subtypes die out? A hypothesis. mBio 2(5):e00150-11. http://dx.doi.org/10.1128/mBio.00150-11.
6. Kilbourne ED. 1997. Perspectives on pandemics: a research agenda. J. Infect. Dis. 176(Suppl 1):S29-S31.
7. Gatherer D. 2009. The 2009 H1N1 influenza outbreak in its historical context. J. Clin. Virol. 45:174-178. http://dx.doi.org/10.1016/j.jcv.2009.06.004.
8. Christman MC, Kedwaii A, Xu J, Donis RO, Lu G. 2011. Pandemic (H1N1) 2009 virus revisited: an evolutionary retrospective. Infect. Genet. Evol. 11:803-811. http://dx.doi.org/10.1016/j.meegid.2011.02.021.
9. Dowdle WR. 1999. Influenza A virus recycling revisisted. Bull. World Health Organ. 77:820-828.
10. Roos R. 2011. Scientists say 1957 pandemic flu virus could return. Center for Infectious Disease Research Policy (CIDRAP), University of Minnesota, Minneapolis, MN.
11. Nabel GJ, Wei CJ, Ledgerwood JE. 2011. Vaccinate for the next H2N2 pandemic now. Nature 471:157-158. http://dx.doi.org/10.1038/471157a.
12. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. 1992. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56:152-179.
13. Xu R, McBride R, Paulson JC, Basler CF, Wilson IA. 2010. Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic. J. Virol. 84:1715-1721. http://dx.doi.org/10.1128/JVI.02162-09.
14. Pappas C, Viswanathan K, Chandrasekaran A, Raman R, Katz JM, Sasisekharan R, Tumpey TM. 2010. Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957. PLoS One 5:e11158. http://dx.doi.org/10.1371/journal.pone.0011158.
15. Schafer J, Khristova ML, Busse TL, Sinnecker R, Kharitonenkov IG, Schrader C, Suss J, Bucher D. 1992. Analysis of internal proteins of influenza A (H2N2) viruses isolated from birds in East Germany in 1983. Acta Virol. 36:113-120.
16. Makarova NV, Kaverin NV, Krauss S, Senne D, Webster RG. 1999. Transmission of Eurasian avian H2 influenza virus to shorebirds in North America. J. Gen. Virol. 80(Part 12):3167-3171.
17. Schafer JR, Kawaoka Y, Bean WJ, Suss J, Senne D, Webster RG. 1993. Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. Virology 194:781-788. http://dx.doi.org/10.1006/viro.1993.1319.
18. Ma W, Vincent AL, Gramer MR, Brockwell CB, Lager KM, Janke BH, Gauger PC, Patnayak DP, Webby RJ, Richt JA. 2007. Identification of H2N3 influenza A viruses from swine in the United States. Proc. Natl. Acad. Sci. U. S. A. 104:20949-20954. http://dx.doi.org/10.1073/pnas.0710286104.
19. World Health Organization. 2002. WHO manual on animal diagnosis and surveillance. WHO, Geneva, Switzerland. http://www.who.int/csr/resources/publications/influenza/en/whocdscsrncs20025rev.pdf.
20. Reed L, Muench H. 1938. A simple method for estimating fifty percent endpoints. Am. J. Hygiene 27:493-497.
21. Oshansky CM, Pickens JA, Bradley KC, Jones LP, Saavedra-Ebner GM, Barber JP, Crabtree JM, Steinhauer DA, Tompkins SM, Tripp RA. 2011. Avian influenza viruses infect primary human bronchial epithelial cells unconstrained by sialic acid alpha2,3 residues. PLoS One 6:e21183. http://dx.doi.org/10.1371/journal.pone.0021183.
22. Palmer DF. 1975. Advanced laboratory techniques for influenza diagnosis, 6th ed. U.S. Department of Health, Education, and Welfare, Public Health Service, Atlanta, GA.
23. Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB. 1979. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 94:287-296. http://dx.doi.org/10.1016/0003-2697(79)90362-2.
24. Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, Zambon M. 2006. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob. Agents Chemother. 50:2395-2402. http://dx.doi.org/10.1128/AAC.01339-05.
25. Matrosovich MN, Gambaryan AS. 2012. Solid-phase assays of receptorbinding specificity. Methods Mol. Biol. 865:71-94. http://dx.doi.org/10.1007/978-1-61779-621-0_5.
26. Moreland AF, Glaser C. 1985. Evaluation of ketamine, ketamine-xylazine and ketamine-diazepam anesthesia in the ferret. Lab. Anim. Sci. 35:287-290.
27. Green CJ, Knight J, Precious S, Simpkin S. 1981. Ketamine alone and combined with diazepam or xylazine in laboratory animals: a 10 year experience. Lab. Anim. 15:163-170. http://dx.doi.org/10.1258/002367781780959107.
28. Boon AC, de Beauchamp J, Hollmann A, Luke J, Kotb M, Rowe S, Finkelstein D, Neale G, Lu L, Williams RW, Webby RJ. 2009. Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J. Virol. 83:10417-10426. http://dx.doi.org/10.1128/JVI.00514-09.
29. Boon AC, de Beauchamp J, Krauss S, Rubrum A, Webb AD, Webster RG, McElhaney J, Webby RJ. 2010. Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model. J. Virol. 84:7662-7667. http://dx.doi.org/10.1128/JVI.02444-09.
30. Kocer ZA, Krauss S, Stallknecht DE, Rehg JE, Webster RG. 2012. The potential of avian H1N1 influenza A viruses to replicate and cause disease in mammalian models. PLoS One 7:e41609. http://dx.doi.org/10.1371/journal.pone.0041609.
31. Nunes SF, Murcia PR, Tiley LS, Brown IH, Tucker AW, Maskell DJ, Wood JL. 2010. An ex vivo swine tracheal organ culture for the study of influenza infection. Influenza Other Respir. Viruses 4:7-15. http://dx.doi.org/10.1111/j.1750-2659.2009.00119.x.
32. Van Poucke SG, Nicholls JM, Nauwynck HJ, Van Reeth K. 2010. Replication of avian, human and swine influenza viruses in porcine respiratory explants and association with sialic acid distribution. Virol. J. 7:38. http://dx.doi.org/10.1186/1743-422X-7-38.
33. Chan RW, Kang SS, Yen HL, Li AC, Tang LL, Yu WC, Yuen KM, Chan IW, Wong DD, Lai WW, Kwong DL, Sihoe AD, Poon LL, Guan Y, Nicholls JM, Peiris JS, Chan MC. 2011. Tissue tropism of swine influenza viruses and reassortants in ex vivo cultures of the human respiratory tract and conjunctiva. J. Virol. 85:11581-11587. http://dx.doi.org/10.1128/JVI.05662-11.
34. Vines A, Wells K, Matrosovich M, Castrucci MR, Ito T, Kawaoka Y. 1998. The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction. J. Virol. 72:7626-7631.
35. Tumpey TM, Maines TR, Van Hoeven N, Glaser L, Solorzano A, Pappas C, Cox NJ, Swayne DE, Palese P, Katz JM, Garcia-Sastre A. 2007. Atwo-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315:655-659. http://dx.doi.org/10.1126/science.1136212.
36. Liu Y, Childs RA, Matrosovich T, Wharton S, Palma AS, Chai W, Daniels R, Gregory V, Uhlendorff J, Kiso M, Klenk HD, Hay A, Feizi T, Matrosovich M. 2010. Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus. J. Virol. 84:12069-12074. http://dx.doi.org/10.1128/JVI.01639-10.
37. Foeglein A, Loucaides EM, Mura M, Wise HM, Barclay WS, Digard P. 2011. Influence of PB2 host-range determinants on the intranuclear mobility of the influenza A virus polymerase. J. Gen. Virol. 92:1650-1661. http://dx.doi.org/10.1099/vir.0.031492-0.
38. Steel J, Lowen AC, Mubareka S, Palese P. 2009. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog. 5:e1000252. http://dx.doi.org/10.1371/journal.ppat.1000252.
39. Pielak RM, Chou JJ. 2010. Flu channel drug resistance: a tale of two sites. Protein Cell 1:246-258. http://dx.doi.org/10.1007/s13238-010-0025-y.
40. Bouvier NM, Lowen AC. 2010. Animal models for influenza virus pathogenesis and transmission. Viruses 2:1530-1563. http://dx.doi.org/10.3390/v20801530.
41. Nguyen JT, Smee DF, Barnard DL, Julander JG, Gross M, de Jong MD, Went GT. 2012. Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses. PLoS One 7:e31006. http://dx.doi.org/10.1371/journal.pone.0031006.
42. Ding H, Tsai C, Gutierrez RA, Zhou F, Buchy P, Deubel V, Zhou P. 2011. Superior neutralizing antibody response and protection in mice vaccinated with heterologous DNA prime and virus like particle boost against HPAI H5N1 virus. PLoS One 6:e16563. http://dx.doi.org/10.1371/journal.pone.0016563.
43. Ilyushina NA, Ikizler MR, Kawaoka Y, Rudenko LG, Treanor JJ, Subbarao K, Wright PF. 2012. Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium. J. Virol. 86:11725-11734. http://dx.doi.org/10.1128/JVI.01477-12.
44. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, QHa do, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12:1203-1207. http://dx.doi.org/10.1038/nm1477.
45. Bodewes R, Kreijtz JH, van Amerongen G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF, Kuiken T. 2011. Pathogenesis of influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation. Am. J. Pathol. 179:30-36. http://dx.doi.org/10.1016/j.ajpath.2011.03.026.
46. Maines TR, Chen LM, Van Hoeven N, Tumpey TM, Blixt O, Belser JA, Gustin KM, Pearce MB, Pappas C, Stevens J, Cox NJ, Paulson JC, Raman R, Sasisekharan R, Katz JM, Donis RO. 2011. Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. Virology 413:139-147. http://dx.doi.org/10.1016/j.virol.2011.02.015.
47. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, Osterhaus AD, Kuiken T. 2006. H5N1 virus attachment to lower respiratory tract. Science 312:399. http://dx.doi.org/10.1126/science.1125548.
48. Driskell EA, Pickens JA, Humberd-Smith J, Gordy JT, Bradley KC, Steinhauer DA, Berghaus RD, Stallknecht DE, Howerth EW, Tompkins SM. 2012. Low pathogenic avian influenza isolates from wild birds replicate and transmit via contact in ferrets without prior adaptation. PLoS One 7:e38067. http://dx.doi.org/10.1371/journal.pone.0038067.
49. Baranovich T, Bridges O, Burnham A, Carey D, Cline TD, Crumpton JC, DeBeauchamp J, Duan S, Ducatez MF, Elbahesh H, Fabrizio T, Forrest HL, Franks J, Freiden P, Govorkova E, Guan Y, Jones JC, Kaplan BS, Karlsson EA, Kercher LA, Koçer ZA, Krauss S, Little B, Marathe BM, McClaren L, McKenzie PP, Meliopoulos VA, O'Brien KB, Oguin TH, III, Oshansky CM, Peiris JSM, Prevost K, Rubrum A, Russell CJ, Sanders C, Seiler P, Seufzer B, Shanmuganatham KK, Sonnberg S, Stoner TD, Jeevan T, Turner J, van de Velde LA, van de Velde N, Walker D, Webby RJ, Webster RG, Wong S-S, Yoon S-W, Zanin M, Zaraket H, Schultz-Cherry SL, Thomas PG. 2013. Assessing the fitness of distinct clades of influenza A (H9N2) viruses. Emerg. Microbes Infect. 2:e75. http://dx.doi.org/10.1038/emi.2013.75.
50. Centers for Disease Control and Prevention. 2012, posting date. Influenza risk assessment tool (IRAT). Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/flu/pandemic-resources/tools/risk-assessment.htm.
51. Lipatov AS, Kwon YK, Sarmento LV, Lager KM, Spackman E, Suarez DL, Swayne DE. 2008. Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses. PLoS Pathog. 4:e1000102. http://dx.doi.org/10.1371/journal.ppat.1000102.
52. Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA. 2006. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312:404-410. http://dx.doi.org/10.1126/science.1124513.
53. Hatta M, Hatta Y, Kim JH, Watanabe S, Shinya K, Nguyen T, Lien PS, Le QM, Kawaoka Y. 2007. Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog. 3:1374-1379. http://dx.doi.org/10.1371/journal.ppat.0030133.
54. Cheung CL, Rayner JM, Smith GJ, Wang P, Naipospos TS, Zhang J, Yuen KY, Webster RG, Peiris JS, Guan Y, Chen H. 2006. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J. Infect. Dis. 193:1626-1629. http://dx.doi.org/10.1086/504723.
55. Yen HL, Ilyushina NA, Salomon R, Hoffmann E, Webster RG, Govorkova EA. 2007. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J. Virol. 81:12418-12426. http://dx.doi.org/10.1128/JVI.01067-07.
56. Yen HL, Lipatov AS, Ilyushina NA, Govorkova EA, Franks J, Yilmaz N, Douglas A, Hay A, Krauss S, Rehg JE, Hoffmann E, Webster RG. 2007. Inefficient transmission of H5N1 influenza viruses in a ferret contact model. J. Virol. 81:6890-6898. http://dx.doi.org/10.1128/JVI.00170-07.
57. Chen GL, Lamirande EW, Yang CF, Jin H, Kemble G, Subbarao K. 2010. Evaluation of replication and cross-reactive antibody responses of H2 subtype influenza viruses in mice and ferrets. J. Virol. 84:7695-7702. http://dx.doi.org/10.1128/JVI.00511-10.